UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (55) 55
life sciences & biomedicine (45) 45
science & technology (45) 45
female (42) 42
male (41) 41
adult (39) 39
middle aged (39) 39
biological and medical sciences (28) 28
medical sciences (28) 28
aged (27) 27
hematology (26) 26
oncology (21) 21
antineoplastic combined chemotherapy protocols - therapeutic use (20) 20
hematologic and hematopoietic diseases (19) 19
adolescent (17) 17
treatment outcome (17) 17
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (16) 16
prognosis (14) 14
antineoplastic agents (13) 13
chemotherapy (13) 13
disease-free survival (13) 13
follow-up studies (11) 11
pharmacology. drug treatments (11) 11
aged, 80 and over (10) 10
cyclophosphamide - administration & dosage (9) 9
neoplasm staging (9) 9
retrospective studies (9) 9
risk factors (9) 9
survival analysis (9) 9
time factors (9) 9
abridged index medicus (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
hodgkin disease - therapy (8) 8
rituximab (8) 8
vincristine - administration & dosage (8) 8
antibodies, monoclonal, murine-derived (7) 7
doxorubicin - administration & dosage (7) 7
prednisone - administration & dosage (7) 7
young adult (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
combined modality therapy (6) 6
hodgkin disease - drug therapy (6) 6
lymphoma, large b-cell, diffuse - drug therapy (6) 6
recurrence (6) 6
antibodies, monoclonal - administration & dosage (5) 5
antineoplastic agents - therapeutic use (5) 5
cancer (5) 5
cytarabine - administration & dosage (5) 5
etoposide - administration & dosage (5) 5
hodgkin disease - pathology (5) 5
hodgkin disease - radiotherapy (5) 5
hodgkin's disease (5) 5
leukemia - etiology (5) 5
lymphoma, non-hodgkin - drug therapy (5) 5
salvage therapy (5) 5
stem cell transplantation (5) 5
tumors (5) 5
bleomycin - administration & dosage (4) 4
care and treatment (4) 4
child (4) 4
clinical trials as topic (4) 4
cyclophosphamide - adverse effects (4) 4
doxorubicin (4) 4
doxorubicin - adverse effects (4) 4
etoposide (4) 4
hodgkin disease - mortality (4) 4
lymphoma (4) 4
lymphoma, non-hodgkin - pathology (4) 4
lymphomas (4) 4
methotrexate - administration & dosage (4) 4
non-hodgkin's lymphomas (4) 4
remission induction (4) 4
survival (4) 4
thrombocythemia, essential - complications (4) 4
thrombosis (4) 4
thrombosis - etiology (4) 4
abvd (3) 3
acute leukemia (3) 3
antimitotic agents (3) 3
bleomycin - adverse effects (3) 3
cause of death (3) 3
cyclophosphamide (3) 3
general & internal medicine (3) 3
general aspects (3) 3
hodgkin disease - diagnostic imaging (3) 3
hodgkin's lymphoma (3) 3
immunochemotherapy (3) 3
italy (3) 3
italy - epidemiology (3) 3
kaplan-meier estimate (3) 3
leucovorin - administration & dosage (3) 3
leukemia (3) 3
leukemia, myeloid, acute - enzymology (3) 3
lymphoma, b-cell, marginal zone - pathology (3) 3
lymphoma, non-hodgkin - complications (3) 3
marginal zone (3) 3
medicine, general & internal (3) 3
multivariate analysis (3) 3
pipobroman (3) 3
positron-emission tomography - methods (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 3, pp. 203 - 212
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Hodgkin's disease | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 08/2017, Volume 18, Issue 8, pp. 1076 - 1088
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 2014, Volume 32, Issue 12, pp. 1188 - 1194
Journal Article
Journal Article
Haematologica (Roma), ISSN 0390-6078, 03/2012, Volume 97, Issue 3, pp. 416 - 422
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 06/2014, Volume 32, Issue 17, pp. 1769 - 1775
Journal Article
Clinical cancer research, ISSN 1078-0432, 11/2006, Volume 12, Issue 21, pp. 6487 - 6493
Journal Article